About US
Contact us
-
Merck & Co sees growth potential in the GulfMerck & Co believes the Gulf region is an area ripe for expansion, especially the United Arab Emirates, driven by its diabetes blockbuster Januvia. The company notes that the UAE ranks second-h2011/12/13
-
Reata, Abbott partner to develop and commercialize AIMs for chronic diseasesAbbott (NYSE: ABT) and Reata Pharmaceuticals today announced that they have entered into a worldwide collaboration to jointly develop and commercialize Reata's portfolio of second-generation oral anti2011/12/13
-
Pfizer Settles Prempro Case After Losing $72.6 Million VerdictBy Jef Feeley and Margaret Cronin Fisk Dec. 9 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, agreed to settle claims that its menopause drugs caused cancer in three women who won a $72.62011/12/12
-
China's Cabinet approves plan to strengthen drug safetyThe State Council, or the Cabinet, on Wednesday （December 7, 2011）approved a blueprint to establish a credit rating system and intensify monitoring for pharmaceutical groups to boost the country's dru2011/12/12
-
Merck to establish China research headquartersUS-based pharmaceutical major Merck & Co is planning to establish a research and development headquarters in Beijing, China, spearheading a five-year investment into research in China worth approx2011/12/9
-
UPDATE 2-AstraZeneca slashes 1,150 U.S. sales jobs* Cuts represent 24 pct of U.S. sales force * Cost of $50-100 mln won't impact 2011 core EPS By Paul Sandle and Ben Hirschler LONDON, Dec 7 (Reuters) - AstraZeneca is cutting nearly a quarter2011/12/9
-
'Me-too' pharma firms will 'disappear' - Roche's SchwanDrugmakers whose offerings do not offer any genuine value are going to "literally disappear" over the next decade, according to Roche's chief executive. Speaking at the FT Pharmaceutical and Biotec2011/12/8
-
China approves plan to strengthen drug safetyBEIJING - The State Council, or the Cabinet, on Wednesday approved a blueprint to establish a credit rating system and intensify monitoring for pharmaceutical groups to boost the country's drug safety2011/12/8
-
Sanofi criticizes study flagging Lantus cancer risk(Reuters) - A Swedish study has rekindled concerns about a possible link between Sanofi's top-selling insulin drug Lantus and cancer, but the French drugmaker said on Wednesday the observational resea2011/12/8
-
Guidance on Management of Laboratory for Drug Clinical Trial Biological Sample Analysis (interim) issuedTo enhance the management of laboratories for drug clinical trial biological sample analysis, and improve the quality and management of analytical data of biological samples, the State Food and Drug A2011/12/7